{
  "title": "What this review means",
  "includeSubclaimIllustrations": false,
  "redteamReviewed": true,
  "accessNotice": "Source checking used bounded original primary abstract passages/status records and selected original partial-body passages. No complete-abstract or complete-paper audit, or independent scientific peer review, is claimed. Detailed access counts and limitations appear in the review.",
  "overview": "Retatrutide causes substantial weight loss in supervised trials; superiority to modern obesity drugs and equivalence of online research vials remain unestablished in this review.",
  "implications": "The registered primary subclaim SC2 supports Ε with Moderate confidence. Retatrutide causes substantial weight loss under supervised trial conditions. Human receptor partition, superiority to modern active comparators and equivalence of online vials require separate evidence. Multiple trials replicate the pharmacological effect; they do not automatically constitute independent causal lines under the frozen shared-failure definition.",
  "limitations": "60 primary reports with 5 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness. The grade applies to the exact registered claim; stronger findings for narrower subclaims remain separate. No complete-paper audit or blinded calibration is claimed. This educational review does not establish an individual treatment recommendation."
}